Active Stocks
Tue Apr 16 2024 15:59:30
  1. Tata Steel share price
  2. 160.05 -0.53%
  1. Infosys share price
  2. 1,414.75 -3.65%
  1. NTPC share price
  2. 359.40 -0.54%
  1. State Bank Of India share price
  2. 751.90 -0.65%
  1. HDFC Bank share price
  2. 1,509.40 0.97%
Business News/ Politics / Policy/  The malaria antidote
BackBack

The malaria antidote

Mint tracks the progress of global research in evolving a malaria vaccine and the success in creating drugs to tackle similar killer diseases

British drug maker GlaxoSmithKline Plc. has sought marketing approval for the world’s first malaria vaccine after clinical trials conducted in Burkina Faso, Africa, showed the shot significantly cut cases of the disease in African children. Photo: Bloomberg (Bloomberg)Premium
British drug maker GlaxoSmithKline Plc. has sought marketing approval for the world’s first malaria vaccine after clinical trials conducted in Burkina Faso, Africa, showed the shot significantly cut cases of the disease in African children. Photo: Bloomberg
(Bloomberg)

In a major scientific breakthrough, the world is on the threshold of creating a vaccine to prevent malaria—which causes 1.2 million deaths globally every year. British drug maker GlaxoSmithKline Plc. has sought marketing approval for the world’s first malaria vaccine after clinical trials conducted in Burkina Faso, Africa, showed the shot significantly cut cases of the disease in African children. Mint takes stock of the progress of global research in evolving a malaria vaccine and also tracks the success in creating vaccines to tackle similar killer diseases.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Politics News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 13 Oct 2013, 11:25 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App